Why the glass half-full is not good enough – improving the diagnosis of TB among people living with HIV
Co-Chairs
Nagalingeswaran KUMARASAMY, VHS Infectious Diseases Medical Centre Voluntary Health Services Chennai, India
Sergio CARMONA, FIND, Switzerland
Organizer
Share
People living with HIV (PLHIV) are at increased risk of developing TB and account for the highest TB-associated mortality. World Health Organization (WHO) recommends frequent symptom-based TB screening for active disease and provision of TB preventive therapy (TPT); however, TB remains under-diagnosed and TPT scale-up limited. Session summary: Overview of current WHO guidance for diagnosing TB in PLHIV, including current and future technologies which may improve TB case detection among PLHIV. In addition, sharing of individual country experiences from three different regions, including targeted universal test and treat (TUTT) as a potential TB case finding strategy at primary healthcare level, to inform future programme interventions.
07:30
5 min
Introduction
FIND, Switzerland
07:35
10 min
Current normative guidance on screening and testing PLHIV for TB
World Health Organization, Australia
07:45
10 min
Why is diagnosing TB difficult for PLHIV – experiences from the South African programmes?
The Aurum Institute, South Africa
07:55
10 min
Why is diagnosing TB difficult for PLHIV – experiences from India programmes?
Sr. CMO (SAG) & DDG, Lab Services & Programme Management Division, National Aids Control Organization (NACO), India
08:05
10 min
Why is diagnosing TB difficult for PLHIV – experiences from the LATAM region
PAHO, Argentina
08:15
10 min
What is in the diagnostic toolkit; current and future tools to support improved diagnosis of TB among PLHIV
FIND, Switzerland
08:25
10 min
Targeted Universal TB Testing (TUTT) among PLHIV – key study findings and lessons learnt
PHRU, South Africa
08:35
25 min
Panel discussion (Q&A)
VHS Infectious Diseases Medical Centre Voluntary Health Services Chennai, India